Ex parte REINHERZ et al. - Page 4




          Appeal No. 94-1483                                                          
          Application No. 07/695,141                                                  



          Description Requirement, 35 U.S.C. § 112, First Paragraph                   
               Claims 14 through 16, 18, 20 through 22, 24 through 28,                
          and 32 through 34 are rejected under 35 U.S.C. § 112, first                 
          paragraph, as based on an inadequate written description of                 
          the claimed invention.                                                      
               These claims are drawn to (1) genetic material, including              
          DNA; (2) an expression vector containing DNA; (3) a                         
          prokaryotic or eukaryotic host cell containing the expression               
          vector; and                                                                 
          (4) a method of culturing the host cell.  They all fall short               
          of complying with the written description requirement of the                
          statute because appellants' specification does not provide the              
          kind of specificity necessary to support them.                              
               As stated in Univ. of Cal. v. Eli Lilly and Co., 119 F.3d              
          1559, 1566-69, 43 USPQ2d 1398, 1404-07 (Fed. Cir. 1997), an                 
          adequate written description of genetic material, such as DNA               
          or cDNA, requires a precise definition, e.g., by structure,                 
          formula, chemical name, or physical properties.  A mere wish                
          or plan for obtaining the claimed chemical invention, or a                  
          general method for obtaining the genetic material involved,                 
          will not do.  What is required is a description of the DNA                  
                                         -4-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007